Skip to main content

Advertisement

Log in

Noncardiac chest pain of esophageal origin

  • Published:
Current Treatment Options in Gastroenterology Aims and scope Submit manuscript

Opinion Statement

Cardiac and musculoskeletal disease should be excluded before considering an esophageal etiology for chest pain.

Acid reflux is a common cause of chest pain and should be identified and treated. A therapeutic trial should consist of a proton pump inhibitor (omeprazole 20 mg or lanzoprazole 30 mg) given one or two times per day for at least 6 to 8 weeks. An alternative is to use an ambulatory pH study to confirm reflux. Also, if the patient fails the initial treatment, reflux should be confirmed with pH testing before increasing the dose of proton pump inhibitor or considering combination or surgical therapy.

Esophageal manometry should be considered in patients with chest pain and dysphagia. It is also reasonable to perform manometry before a pH study since manometric localization of the lower esophageal sphincter (LES) is needed to ensure accurate pH probe placement.

Only after manometric confirmation of a spastic esophageal motility disorder should patients be treated for esophageal spasm. In these patients, it is reasonable to try a long-acting formulation of a calcium-channel blocker or nitrate.

Patients with chest pain who have a negative cardiac evaluation and who do not have reflux may have an abnormality in esophageal or cardiac sensation. These patients should be treated with a trial of an antidepressant and considered for referral to a mental health practitioner.

All medication trials should continue at least 6 to 8 weeks to avoid a placebo effect and to allow adequate time for a therapeutic response.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References and Recommended Reading

  1. Svensson O, Stenport G, Tibbling L, Wranne B: Oesophageal function and coronary angiogram in patients with disabling chest pain. Acta Med Scand 1978, 204:173–178.

    Article  PubMed  CAS  Google Scholar 

  2. Ros E, Armencol X, Grande L, et al.: Chest pain at rest in patients with coronary artery disease: myocardial ischemia, esophageal dysfunction or panic disorder. Dig Dis Sci 1997, 42:1344–1361.

    Article  PubMed  CAS  Google Scholar 

  3. Panju A, Farkouh ME, Sackett DL, et al.: Outcome of patients discharged from a coronary care unit with a diagnosis of “chest pain not yet diagnosed.” Can Med Assoc J 1996, 155:541–546.

    CAS  Google Scholar 

  4. Cannon RO, Epstein SE: “Microvascular angina” as a cause of chest pain with angiographically normal coronary arteries. Am J Cardiol 1988, 61:1338–1343.

    Article  PubMed  Google Scholar 

  5. Locke GR, Talley NJ, Fett SL, et al.: Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997, 112:1148–1152.

    Article  Google Scholar 

  6. Hewson EG, Sinclair JW, Dalton CB, Richter JE: Twentyfour-hour esophageal pH monitoring: the most useful test for evaluating noncardiac chest pain. Am J Med 1991, 90:576–583. In this landmark study, up to 71% of patients with chest pain were found to have some degree of gastroesophageal reflux disease.

    PubMed  CAS  Google Scholar 

  7. Kahrilas PJ, Clouse RE, Hogan WJ: American Gastroenterological Association technical review on the clinical use of esophageal manometry. Gastroenterology 1994, 107:1865–1884.

    PubMed  CAS  Google Scholar 

  8. Just RJ, Castell DO: Chest pain of undetermined origin. Gastrointest Endosc Clin N Am 1994, 4:731–746.

    PubMed  CAS  Google Scholar 

  9. Rao SS, Gregersen H, Hayek B, et al.: Unexplained chest pain: the hypersensitive, hyperreactive, and poorly compliant esophagus. Ann Intern Med 1996, 124:950–958.

    PubMed  CAS  Google Scholar 

  10. Smout AJPM, DeVore MS, Dalton CB, Castell DO: Cerebral potentials evoked by oesophageal distension in patients with noncardiac chest pain. Gut 1992, 33:298–302.

    PubMed  CAS  Google Scholar 

  11. DeVault KR, Castell DO: Guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Arch Intern Med 1995, 155:2165–2173.

    Article  PubMed  CAS  Google Scholar 

  12. Stahl MG, Beton RR, Johnson CS, et al.: Diagnosis and treatment of patients with gastroesophageal reflux and noncardiac chest pain. South Med J 1994, 87:739–742.

    Article  PubMed  CAS  Google Scholar 

  13. Galmiche JP, Brandstatter G, Evreux M, et al.: Combined therapy with cisapride and cimetidine in severe reflux oesophagitis: a double blind placebo-controlled trial. Gut 1988, 29:675–681.

    PubMed  CAS  Google Scholar 

  14. Leite LP, Johnson BT, Just RJ, Castell DO: Persistent acid secretion during omeprazole therapy: a study of gastric acid profiles in patients demonstrating failure of omeprazole therapy. Am J Gastroenterol 1996, 91:1527–1531.

    PubMed  CAS  Google Scholar 

  15. Ongnena P, Van Houndenhove B: Antidepressant-induced analgesia in chronic non-malignant pain: a meta-analysis of 39 placebo-controlled studies. Pain 1992, 449:205–219.

    Article  Google Scholar 

  16. Myren J, Lovland B, Larssen SE, Larsen SA: Double-blind study of the effect of trimipramine in patients with the irritable bowel syndrome. Scand J Gastroenterol 1984, 19:835–843.

    PubMed  CAS  Google Scholar 

  17. Orlando RC, Bozymski EM: Clinical and manometric effects of nitroglycerin in diffuse esophageal spasm. N Engl J Med 1980, 303:1249–1252.

    Article  Google Scholar 

  18. Swamy GL: Esophageal spasm: Clinical and manometric response to nitroglycerin and long acting nitrates. Gastroenterology 1977, 72:23–27.

    PubMed  CAS  Google Scholar 

  19. Richter JE, Dalton CB, Bradley LA, et al.: Oral nifedipine in the treatment of noncardiac chest pain in patients with the nutcracker esophagus. Gastroenterology 1987, 93:21–28.

    PubMed  CAS  Google Scholar 

  20. Cattau EL, Castell DO, Johnson DA, et al.: Diltiazem therapy of symptoms associated with nutcracker esophagus. Am J Gastroenterol 1991, 86:272–276.

    PubMed  Google Scholar 

  21. DeMeester TR: Surgery for esophageal motor disorders. Ann Thorac Surg 1982, 34:225–229.

    Article  PubMed  CAS  Google Scholar 

  22. Achem SR, Kolts BE, Wars R, et al.: Chest pain associated with nutcracker esophagus: a preliminary study of the role of gastroesophageal reflux. Am J Gastroenterol 1993, 88:187–192.

    PubMed  CAS  Google Scholar 

  23. Bradette M, Delvaux M, Staumont G, et al.: Octreotide increases thresholds of colonic visceral perception in IBS patients without modifying muscle tone. Dig Dis Sci 1994, 39:1171–1178.

    Article  PubMed  CAS  Google Scholar 

  24. Johnson BT, Shils J, Khan A, et al.: Effects of octreotide (Sandostatin) on esophageal visceral perception and cerebral evoked potentials. Gastroenterology 1996, 110:A145.

    Google Scholar 

  25. Hazan W, Bukley E, Castell DO, Achem SR: Octreotide improves sensory and pain thresholds in patients with noncardiac chest pain. Gastroenterology 1996, 110:A132.

    Google Scholar 

  26. Clouse RE, Lustman PJ, Eckert TC, et al.: Low-dose trazodone for symptomatic patients with esophageal contraction abnormalities: a double-blind, placebo-controlled trial. Gastroenterology 1987, 92:1027–1036.

    PubMed  CAS  Google Scholar 

  27. Cannon RO, Quyyumi AA, Mincemoyer R, et al.: Imipramine in patients with chest pain despite normal coronary angiograms. N Engl J Med 1994, 330:1411–1417. The authors report on a large group of extensively studied patients with noncardiac chest pain who achieved significant improvement in their pain with imipramine compared with placebo.

    Article  PubMed  Google Scholar 

  28. Hongo M, Traube M, McCallum RW: Comparison of effects of nifedipine, probanthine bromide and the combination on esophageal motor function in normal volunteers. Dig Dis Sci 1984, 29:300–304.

    Article  PubMed  CAS  Google Scholar 

  29. Blackwell JN, Dalton CB, Castell DO: Oral pirenzepine does not affect esophageal pressures in man. Dig Dis Sci 1986, 31:230–235.

    Article  PubMed  CAS  Google Scholar 

  30. Bassotti G, Gaburri M, Imbimbo BP, et al.: Manometric evaluation of cimetropium bromide activity in patients with nutcracker esophagus. Scand J Gastroenterol 1988, 23:1079–1084.

    PubMed  CAS  Google Scholar 

  31. Mellow MH: Effect of isosorbide and hydralazine in painful esophageal motility disorders. Gastroenterology 1982, 83:304–370.

    Google Scholar 

  32. Winters C, Artnak EJ, Benjamin SB, Castell DO: Esophageal bougienage in symptomatic patients with nutcracker esophagus. JAMA 1984, 252:363–366.

    Article  PubMed  CAS  Google Scholar 

  33. Beitman BD, Basha IM, Trombka LH, et al.: Pharmacotherapeutic treatment of panic disorder in patients presenting with chest pain. J Fam Pract 1989, 28:177–180.

    PubMed  CAS  Google Scholar 

  34. Klimes I, Mayou RA, Pearce MJ, et al.: Psychological treatment of atypical non-cardiac chest pain: a controlled evaluation. Psychol Med 1990, 20:605–611.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

DeVault, K.R., Achem, S.R. Noncardiac chest pain of esophageal origin. Curr Treat Options Gastro 1, 49–55 (1998). https://doi.org/10.1007/s11938-998-0008-8

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11938-998-0008-8

Keywords

Navigation